DANSK BIOTEK invites to seminar September 23, 2010 at 14.30
HØIBERG A/S, Store Kongensgade 59 A, 1264 Copenhagen K
14.30 Registration and networking
15.00 Welcome and comments
Martin Bonde, CEO, Epitherapeutics A/S, Member of the board, DANSK BIOTEK
15.05 How to build value with IP from a biotech company perspective
Li Westergaard, Vice President Global IP, Bavarian Nordic Inc.
15.30 What is the venture capital investor looking for in terms of IP, when investing in a biotech company?
Kim Dueholm, Partner, Novo Ventures, Novo A/S
15.50 When am I allowed to use patented compounds in my own development work?
Susanne Høiberg, CEO and Partner, European Patent & Trademark Attorney, HØIBERG A/S
16.10 US vs. European patent law – what to look out for
Antony C. Tridico, Managing Partner, Finnegan
16.35 A short presentation of the patent agencies in Denmark (members of DANSK BIOTEK) and concluding remarks by Martin Bonde
DANSK BIOTEK and HØIBERG A/S invite to refreshments and networking oportunities
Please registre below, no later than 16th of September 2010.
The fee for participation is 500 DKK. Participation for members of DANSK BIOTEK is free of charge.
In absent without cancelation a fee on 500 DKK will be charged.
Member of the board